




















































































New ICD-9- CM Codes for 2010 

ICD-9-CM Code Additions and Changes 
The 2010 updates to the ICD-9-CM procedure code list went into effect on October 1, 2009. 

The NHSN Operative Procedures Category table has been updated to reflect these changes 

and is available by clicking on this link http://www.cdc.gov/nhsn/PDFs/
 






Likewise, the complete ICD-9-CM procedure list with companion NHSN operative procedure codes has also 

been updated and can be found at http://www.cdc.gov/nhsn/PDFs/ICD-9-cmCODEScurrent.pdf. These 

changes, shown below, are effective immediately.
 
Updates: 2009-10 High Risk Inpatient Influenza Vaccination Module (HRIIV)
Seasonal and Non-seasonal Flu Vaccination
NHSN has updated the High Risk Inpatient Influenza Vaccination (HRIIV) Module to include vaccination
for both seasonal and non-seasonal (e.g. H1N1) subtypes. Highlights of the HRIIV Module:
	 Method A, the summary method, allows for calculation of prevalence of admissions meeting 
high risk criteria for both subtypes of influenza vaccine and percent adherence to and declina-
tion of vaccination. 
For each influenza vaccination subtype, a High Risk Inpatient Influenza Vaccination Monthly 
Monitoring Form A  is completed each month the module is followed in your facility. 
(Continued on page 2) 
ICD-9-CM code New NHSN Operative Procedure 
Category
Notes
17.51 Implantation of re-
chargeable cardiac contractility 
modulation [CCM], total system
PACE New ICD-9-CM code 
17.52 Implantation of re-
chargeable cardiac contractility 
modulation [CCM], recharge-
able pulse generator only
PACE New ICD-9-CM code 
46.87 Other insertion of colo-
nic stent(s)
OTH New ICD-9-CM code 
39.53 Repair of arteriovenous 
fistula 
ASVD Previously OTH 
84.51 Insertion of interbody 
spinal fusion device
OTH Previously FUSN, however, this 
will always be a secondary pro-
cedure to FUSN
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There will be a new option available in the MDRO/CDAD Mod-
ule beginning with the first NHSN update release of 2010.  
Facilities will be able to specify in the Monthly Reporting 
Plan the option to monitor Overall Facility-Wide LabID Event
reporting of Blood Specimens Only for any of the MDROs 
(MRSA, VRE, MDR-Klebsiella, and MDR-Acinetobacter, but not 
C. difficile).  Currently the only option for LabID Event report-
ing is to enter all specimen sources as LabID Events for a
specified MDRO.  This new update allows for the monitoring of 
bloodstream infections only, and once released this option
will be available on the Monthly Reporting Plan.  Please note
that this option will not take effect immediately at the start of  






























Cont’d. HRIIV Module Updates  NHSN Drops CSEP Requirement for 2010  
(Continued from page 1) As of January 1, 2010, Clinical Sepsis (CSEP) will no longer be a 
specific event type in NHSN, and therefore will not be required 
	 Method B allows for more complete overview of the facility 
efforts for influenza vaccination of inpatients. In addition to the 
metrics above, patient-level data for high risk inpatients not 
receiving vaccination are collected.  This method allows identi-
fication of failures of adherence to guidelines. 
For each high risk patient admitted during months monitored,
a High Risk Inpatient Influenza Vaccination Method B Form
Part 1 and/or Part 2 is completed for each influenza vaccina-
tion subtype offered to the patient. 
For each influenza vaccination subtype, a High Risk Inpatient 
Influenza Vaccination Monthly Monitoring Form B is completed 
each month the module is followed in your facility. 
under CLABSI reporting for the Device-Associated Module.  The 
ability to enter information will remain in the system for several
months allowing users to complete their 2009 CSEP events. 
As a review, NHSN’s CSEP event type was used only for neo-
nates (≤ 30 days old) and infants (≤ 1 year old).  It was reported 
by facilities monitoring central line-associated bloodstream 
infections in neonatal and pediatric units.  Some of the chal-
lenges identified using this event type that contributed to this 
change, included a subjective, non-specific definition which was
labor-intensive to collect.
The optional High Risk Inpatient Influenza Vaccination 
“The optional High Risk Inpatient Standing Orders Form is available for use and contains 
the information needed to report using either Method A Influenza Vaccination Standing Orders 
or B. Form is available for use and contains 
the information needed to report using National focus continues related to efforts to vaccinate 
either Method A or B.”inpatients at high risk of influenza.  The updated NHSN
HRIIV Module offers a surveillance and documentation
system to do this which can assist in identification of activities that pro-
mote improved vaccination rates. 
Cont’d. Lab ID Events  AUR Module Under Reconstruction 
(Continued from page 1) 
the new year. However, once it is released 
(estimate is late January/early February), 
an announcement will be sent, and at that 
time, data can be retro-entered back to 
January 1, 2010.  
Outpatient Procedure
Recently, the Outpatient field on the SSI 
form/screen has been causing some con-
fusion and has led to certain events not 
being conferred to groups when they
should be.  It is meant to refer to the pro-
cedure (i.e., was this procedure per-
formed in an outpatient setting?), not to 
the SSI event (i.e., did this event occur in 
an outpatient?), even though the field is 
in the Event Details section of the form/ 
screen. For clarification purposes, the 
word “procedure” will be added on the 
SSI form/screen so that the field will read: 
“Outpatient Procedure.”  Look for this 
change in early 2010. 
We are excited to announce that the AUR Mod-
ule is undergoing transition to only capture
pharmacy and microbiology data by electronic 
means.  The content, including the antimicro-
bial use metric, will also be updated during 
this transition. 
In January 2010, we plan to start this transi-
tion by discontinuing manual entry of AUR 
Module data. Thus, we request that facilities
no longer submit these data collected for 
months in 2010.
Note to Users—Did You Know…?  
It is anticipated that the launch of the AUR 
Module pharmacy option will occur in late
2010/early 2011, while the microbiology 
option is still under development.  Updates 
in the timeline of launching the AUR Module
will be provided in future E-News.  We hope 
that you consider future participation in the 
AUR Module via electronic submission.  
Using NHSN for Out-of-Plan Surveil-
lance 
Please be careful when using NHSN for 
purposes other than reporting HAI data to 
CDC.  For instance, if entering central line
days into NHSN, in order to identify monthly 
totals for another project, but not entering 
central line-associated bloodstream infec-
tion (CLABSI) events, you must ensure that
your Monthly Reporting Plan does not in-
clude CLABSI surveillance for that location 
in that month.  Not doing so would result in
CLABSI rates of zero being reported to 
NHSN and utilized in national aggregate 
compilation.
Importing Operative Procedures
 The link for importing operative proce-
dure or surgeon data in the Patient Safety 
Component has been moved. It is now its 
own link, “Import/Export” on the left navi-
gation bar.














   










Tracking C. difficile in the NHSN MDRO/CDAD Module Out-of-Plan or by Using Custom Events   
When facilities choose not to file a Monthly Reporting Plan that includes C. difficile under the MDRO/CDAD Module, but want to enter C. diffi-
cile events, these events are considered Out-of-Plan.  Such events may be CDC-defined events (GI-GIT or GI-GE) that include C. difficile as one
of the three reported pathogens (code=CD), or a custom event that is named such that entering pathogen data is not necessary (e.g., CDIFF-
C. difficile Infection).  To obtain output that includes these events, you will need to use the advanced analysis features of NHSN.  You will 
need to follow these same steps whether running a Line Listing, Frequency Table, Bar/Pie Chart, or Rate Table for these data. 
In NHSN, go to: Analysis – Output Options – Advanced – Event Level Data – CDC Defined Output – Line Listing All Events – Modify.  If you 
have entered a pathogen for each of your events, go to “Specify Other Selection Criteria” and set pathogen1=CD or pathogen2=CD or patho-
gen3=CD (according to the screen shot below) and you will obtain a line list of all events with CD as the pathogen. 
If you have not entered a pathogen for each of your events, because you are using a facility-defined custom event
that doesn’t include pathogens, go to “Specify Other Selection Criteria” and set customEventType equal to the 
name you have given the C. difficile event (e.g., CDIFF) (refer to screen shot below), and you will obtain a line list of 
all your C. difficile custom event entries, as long as your named customEventType is used only to report C. difficile. 
You will notice that the generic “CUSPS” code will be displayed in the output rather than the actual code (e.g., CDIFF), so you may choose to 
export your output to a file so you can edit it.  
MDRO/CDAD Module Tips 
1) Please be aware that the LabID Event reporting is ONLY for collecting and tracking positive MRSA cultures that are taken 
for "clinical" purposes (i.e., for diagnosis and treatment), which means that NO Active Surveillance Culture/Testing (ASC/ 
AST) results are to be included in this reporting of individual results.   Do NOT enter surveillance nasal swabs or other surveillance cul-
tures as reports of LabID Events.  AST tracking should be recorded under Process & Outcome Measures.   This is where aggregate totals 
from a location in a month  should be recorded to follow admission and discharge/transfer AST adherence as well as AST prevalence and 
incidence.  If using the MDRO/CDAD Module for LabID Event reporting and/or AST surveillance, please refer to pages 12-5 to 12-7 and 12-
10 to 12-13 of the protocol for details: http://www.cdc.gov/nhsn/PDFs/pscManual/12pscMDRO_CDADcurrent.pdf.  If Active Surveillance 
Testing results  have been entered as LabID Events,  these incorrect  events need to be deleted immediately. 
 2) If a specimen collected in the ED is positive for an MDRO or CDAD, and the patient it is collected from is admitted to the facility on the
SAME date into a location that is monitoring LabID Events for the identified MDRO or CDAD, then that specimen can be reported as the 
first specimen for the patient in that admitting inpatient location for the month.  If the facility is also monitoring LabID Events for the same 
MDRO or CDAD in the ED, then the same specimen for the patient would also be reported a second time for the outpatient ED loca-
tion.  Because of existing business rules for edit checks in NHSN, the date of specimen collection must be the same date or later than the 
admission date. 
 3) Monitoring for C. difficile in the NHSN MDRO and CDAD Module should not be conducted in NICUs or Well Baby Nurseries.  If conduct-
ing overall facility-wide LabID Event reporting this means that the user must remember to subtract patient-days and admission counts 
attributed to these locations before reporting monthly overall facility-wide denominators.
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NHSN Application and Manual Updates 
The most recent updates to the NHSN Application and Manual are described in the following table.
Location of Application Updates Description of Update 
 Surveys> Add For the Healthcare Personnel Safety Component Annual Facility Survey, NHSN will
now allow entry of counts of up to 6 digits for “Outpatient Encounters” and up to 9 
digits for “Hours worked by all employees.”  
 Analysis> Advanced> Event level Data> CDC 
Defined Output
To facilitate exportation of the analysis data sets (Infections; Non-infections) a few 
additions have been made to the previously available options.  In some facilities, 
the Line Listing –All Events was too big for export.  These changes address that
problem. Choices for analysis now include the following: 
Line Listing - All Infection Events: Includes all CDC-HAI events (e.g., PNEU, BSI, UTI), 
as well as facility-defined custom events. 
Line Listing - All Dialysis and Non-Infection Events: In addition to Dialysis Events, 
this line list includes LabID Events, CLIP, and high-risk inpatient influenza vaccina-
tions (FLUVX).  
*Location of Manual Updates Description of Update 
 Chapter 2: Identifying Healthcare-associated
Infections in NHSN
A reference to Chapter 17 was corrected from “ Table 17” to “Chapter 17.” 
 Chapter 6: Ventilator-associated Pneumonia 
Event
Insertion of missing values for pulse oximetry into Table 2 for both sets of alternate 
criteria. 
 Chapter 12: MDRO/CDAD Module Update In the Calculated CDI Prevalence Rates section and Table 2,  the addition of a note
under the formula for “Location Percent Admission Prevalence that is Community 
Onset” that the numerator does not include Admission Prevalent LabID Events that
are Community Onset-Healthcare Facility-associated.  
 Chapter 14: Tables of Instructions Addition of the following in the Pathogens Identified field: For SUTI with secondary 
BSI and ABUTI, enter only the matching organism(s) identified in both urine and 
Table 5:  Instructions for Completion of Urinary blood cultures.  
Tract Infection (UTI) Form  
 Chapter 15: 1. A new CDC Location has been added for use in the Healthcare Personnel 
Facility Location Additions: 
Safety Component: “Float.” This location should be set up and used for HCWs
who do not work at least 75% of the time at a single location. For example: a 
radiology technician who performs portable x-rays throughout multiple patient
care areas would be assigned a work location of Float. 
2. “Antenatal Care Ward” has been added for use in all NHSN Components.  This 
location is described as a “Hospital area for observation, evaluation, treat-
ment, or surgery of high risk pregnancy patients.”
 Chapter 16:
Key Terms
The definition of Secondary Bloodstream Infection has been supplemented to
clarify that documentation of HAI infection at another site must meet CDC criteria
of infection. 


































Q: The NHSN operative proce-
dure category CARD includes 
ICD-9-CM code 37.25, cardiac 
biopsy.  Should cardiac biop-
sies that are performed percutane-
ously be included in surveillance of 
SSIs in the NHSN operative proce-
dures category of CARD? 
A: Even though the ICD-9-CM code 37.25 
includes both open and percutaneously 
performed cardiac biopsies, procedures 
performed percutaneously do not meet the 
definition of an NHSN operative procedure.  
Therefore such procedures should not be 
included in the denominators for CARD SSI
rates, and any associated postoperative
infections should not be included as SSIs in 
the numerator, either.  Such an infection
may be a healthcare-associated infection 
(HAI), but it cannot be an SSI.  Cardiac biop-
sies performed through an open incision
should continue to be included in the sur-
veillance of CARD SSIs 
Q: If a patient who is admitted to a facility 
and found to be positive for methicil-
lin-resistant Staphylococcus aureus 
(MRSA) upon admission screening 
develops an infection with MRSA, is 
that infection a healthcare-associated
infection?
Questions & Answers    

A: A positive screening culture at ad-
mission does not mean that any sub-
sequent infection with that organism 
is not a healthcare-associated infec-
tion (HAI).  Many HAIs are due to or-
ganisms from endogenous patient
sources.  If the patient meets all of the 
CDC/NHSN criteria for a healthcare-
associated infection (see  http:// 
www.cdc.gov/nhsn/PDFs/ 
pscManual/17pscNosInfDef_current.p 
df ), and if that patient had no symp-
toms of infection present or incubating 
at the time of admission, then an HAI 
should be reported. A positive screen-
ing culture without evidence of infec-
tion represents colonization NOT incu-
bation. 
Q: What does the field “date of access” 
mean on the Dialysis Event (DE) form/ 
screen?
A: This date is the date that the ac-
cess device was placed.  This is cur-
rently not specified anywhere in the 
DE module protocol, but will be ad-
dressed in the next version. 
Q: How do I record an "Estimated Blood 
Loss" for a C-section when the amount
exceeds 2000 ml?
A: Record 2000 ml when the
"Estimated Blood Loss" is equal to or 
greater than 2000 ml.
Q: How should PICC (Peripherally In-
serted Central Catheter) Nurses be
recorded in the "Occupation of
Reporter" field of a CLIP event?
A: PICC Nurses should be recorded 
as "IV Team." Please do not report 
PICC Nurses as “Other.” 
Q: How should non-observed or missing 
practice information be recorded 
in CLIP surveillance?  For example, 
if the observer enters the room 
after the procedure has begun, 
how should hand washing be re-
corded, since it was not observed?
A: Efforts should be made to keep 
such occurrences to a minimum. Non-
observed or missing practice informa-
tion should be recorded as "No" on
the CLIP Event Form.   
The Centers for  Disease Contro l  
and Prevent ion (CDC)
MS-A24 

1600 Clifton Rd 

Atlanta, GA 30333  

Phone: 800-CDC-INFO (800-232-4636)  





CDC's NHSN Web site:  www.cdc.gov/nhsn
The National Healthcare Safety Network (NHSN) is a voluntary, secure, inter-
net-based surveillance system that integrates patient and healthcare person-
nel safety surveillance systems managed by the Division of Healthcare Qual-
ity Promotion (DHQP) at CDC. 
During 2008, enrollment in NHSN was opened to all types of healthcare facili-
ties in the United States, including acute care hospitals, long term acute care 
hospitals, psychiatric hospitals, rehabilitation hospitals, outpatient dialysis 
centers, ambulatory surgery centers, and long term care facilities. 
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